ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,050,536 | -10.8% | 390,524 | +1.3% | 0.84% | -10.2% |
| Q1 2024 | $17,991,525 | -2.4% | 385,340 | 0.0% | 0.94% | -4.0% |
| Q4 2023 | $18,426,959 | +33.5% | 385,340 | -0.5% | 0.98% | +17.2% |
| Q3 2023 | $13,808,065 | -32.0% | 387,323 | -12.0% | 0.83% | -24.3% |
| Q2 2023 | $20,303,704 | +30.3% | 440,141 | +13.3% | 1.10% | +19.7% |
| Q1 2023 | $15,579,973 | +33.0% | 388,528 | +53.7% | 0.92% | +26.7% |
| Q4 2022 | $11,714,633 | +18.8% | 252,852 | +6.1% | 0.73% | +16.5% |
| Q3 2022 | $9,864,000 | -0.6% | 238,204 | +43.2% | 0.62% | +8.3% |
| Q2 2022 | $9,924,000 | -25.0% | 166,338 | -8.7% | 0.58% | -1.7% |
| Q1 2022 | $13,232,000 | -34.6% | 182,204 | -24.3% | 0.58% | -18.1% |
| Q4 2021 | $20,246,000 | +120.4% | 240,769 | +136.3% | 0.71% | +124.5% |
| Q3 2021 | $9,188,000 | -57.0% | 101,877 | -54.5% | 0.32% | -54.5% |
| Q2 2021 | $21,366,000 | -21.5% | 224,082 | -6.3% | 0.70% | -22.6% |
| Q1 2021 | $27,215,000 | -10.0% | 239,023 | +9.4% | 0.90% | -14.2% |
| Q4 2020 | $30,232,000 | +62.5% | 218,390 | -17.4% | 1.05% | +18.9% |
| Q4 2016 | $18,600,000 | -0.9% | 264,546 | 0.0% | 0.88% | -7.3% |
| Q3 2016 | $18,767,000 | +250.4% | 264,546 | +405.8% | 0.96% | +130.7% |
| Q2 2015 | $5,356,000 | +46.8% | 52,305 | -14.7% | 0.41% | +38.5% |
| Q1 2015 | $3,649,000 | -10.7% | 61,325 | -34.1% | 0.30% | -15.8% |
| Q4 2014 | $4,085,000 | +72.5% | 93,105 | +122.5% | 0.36% | +56.4% |
| Q3 2014 | $2,368,000 | +51.9% | 41,846 | +20.5% | 0.23% | +58.7% |
| Q2 2014 | $1,559,000 | +41.6% | 34,734 | +54.2% | 0.14% | +36.2% |
| Q1 2014 | $1,101,000 | – | 22,530 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
| Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
| Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
| AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
| EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
| FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
| HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
| Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |